Bank of America cuts target for Aflac stock to USD 133.00
Published on 10/14/2026 at 15:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and calendar
- Bank of America lowered its Aflac target from USD 137.00 to USD 133.00 on October 13, 2026.
- Aflac plans to release third-quarter results on November 4, 2026.
- Aflac stock costs EUR 104.55 at Lang & Schwarz on October 14, 2026 at 3:09 p.m. CEST.
- Aflac had a 12.55 times earnings valuation and USD 59.3 billion market capitalization as of October 13, 2026.
Bank of America lowered its Aflac price target from USD 137.00 to USD 133.00 while maintaining a Buy rating, according to MarketBeat on October 13, 2026. Aflac stock was trading at EUR 104.55 at Lang & Schwarz on October 14, 2026 at 3:09 p.m. CEST.
Results arrive November 4
Aflac plans to release its third-quarter 2026 financial results after the US market closes on November 4, 2026, according to the company's investor-relations release dated September 30, 2026. The release also schedules a webcast for 8:00 a.m. ET on November 5, 2026, giving investors a defined date for the next earnings update.
The calendar matters because the latest reported quarter included USD 4.22 billion in revenue and USD 1.75 in earnings per share, according to MarketBeat's October 13, 2026 report. Revenue was down 1.00 percent year over year, while earnings per share came in below the USD 1.76 consensus estimate.
Valuation remains in the insurance frame
Aflac's market capitalization was USD 59.3 billion and its price-to-earnings ratio was 12.55 as of October 13, 2026. The trailing dividend yield was 2.00 percent, while the NYSE-listed stock's 52-week range was USD 105.43 to USD 130.22.
The valuation places Aflac alongside other large US life insurers. MetLife carried a price-to-earnings ratio of 19.32 and a USD 64.8 billion market capitalization, while Prudential Financial had a ratio of 10.21 and a USD 39.4 billion market capitalization as of October 13, 2026.
Supplemental coverage drives the mix
Aflac operates through US and Japan businesses that provide supplemental health and life insurance. Its products include accident, cancer, critical illness, hospital, disability, dental, vision and life coverage, giving the company exposure to both employer benefits and individual policies.
Trading level in euros
The Lang & Schwarz quote puts the stock at EUR 104.55 on October 14, 2026 at 3:09 p.m. CEST. The price is an intraday indication for German-market investors, while the NYSE listing remains the company's primary exchange.
The further course of trading is shown by the continuously updated real-time quote of Aflac stock.
Aflac stock at a glance
- Company: Aflac Incorporated
- ISIN: US0010551028
- Ticker: AFL
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 14, 2026, 3:09 p.m. CEST): EUR 104.55
- Market capitalization: USD 59.3 billion (as of October 13, 2026)
- 52-week range: USD 105.43-130.22 (as of October 13, 2026)
- Sector / Industry: Financial Services / Life Insurance
- Index membership: S&P 500
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
